1. Banchereau, J. and Steinman, R. M. 1998. Dendritic cells and the control of immunity. Nature392:245.
2. Lodge, P. A., Jones, L. A., Bader, R. A., Murphy, G. P. and Salgaller, M. L. 2000. Dendritic cell-based immunotherapy of prostate cancer: immune monitoring of a phase II clinical trial. Cancer Res.60:829.
3. Sallusto, F. and Lanzavecchia, A. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J. Exp. Med.179:1109.
4. Pickl, W. F., Majdic, O., Kohl, P., Stöckl, J., Riedl, E., Scheinecker, C., Bello-Fernandez, C. and Knapp, W. 1996. Molecular and functional characteristics of dendritic cells generated from highly purified CD14+ peripheral blood monocytes. J. Immunol.157:3850.
5. Palucka, K. A., Taquet, N., Sanchez-Chapuis, F. and Gluckman, J. C. 1998. Dendritic cells as the terminal stage of monocyte differentiation. J. Immunol.160:4587.